Tag: ESC 2025
Intensive cholesterol lowering fails to shift the dial on vein graft failure
Intensive LDL cholest...
Medtech Insights: Edwards’ Brüls outlines company’s move to specialise on structural heart disease
When Cardiovascular N...
ESC 2025: Studies shed new light on antiplatelet therapy after CABG surgery
New evidence offers f...
ESC 2025: Baxdrostat shows promise in lowering blood pressure in uncontrolled and resistant hypertension
Results from the BaxHTN ...
SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes
Drug-coated balloons ...
ESC 2025: REBOOT prompts rethink on use of beta blockers in uncomplicated MI
Beta-blocker therapy appe...
ESC 2025: Trial results add digitoxin as an option for patients with advanced heart failure
Digitoxin reduced the...
